Congestive Heart Failure News and Research

RSS

Congestive Heart Failure is a condition in which the heart can't pump blood the way it should. In some cases, the heart can't fill with enough blood. In other cases, the heart can't send blood to the rest of the body with enough force. Some people have both problems. "Heart failure" doesn't mean that your heart has stopped or is about to stop working. However, it's a serious condition that requires medical care. Heart failure develops over time as the pumping of the heart grows weaker. It can affect the right side of the heart only or both the left and right sides of the heart. Most cases involve both sides of the heart.

New book documents groundbreaking studies on modified citrus pectin

One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis.

4 Jun 2014

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Trimel Pharmaceuticals Corporation announced today that the United States Food and Drug Administration (FDA) has approved Natesto (testosterone), formerly CompleoTRT, the first and only testosterone nasal gel for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

29 May 2014

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Sanofi Pasteur, the vaccines division of Sanofi, presented Phase II (H-030-012) trial results for an investigational vaccine for the prevention of Clostridium difficile infection at the 114th General Meeting of the American Society for Microbiology.

20 May 2014

Higher BMI linked with reduced mortality risk in patients with pulmonary hypertension

In patients with congestive heart failure, obesity and a larger waist size have paradoxically been associated with a better prognosis in the prior investigations. This effect, known as the obesity paradox phenomenon, is now being demonstrated in patients with severe pulmonary hypertension.

20 May 2014

Investigators find effective treatment for life-threatening angioedema attacks in ED

Investigators at the University of Cincinnati have found a safe and effective treatment for life-threatening angioedema attacks in the emergency department.

15 May 2014

Intensive insulin treatment improves survival for diabetic heart attack patients

Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.

14 May 2014

Study reveals sea salt and table salt have equivalent sodium content

Pink Himalayan, Breton Gray and Hawaiian Alea - the newer offerings of salt may be exotic, cost more and frequent the shelves of high-end stores, but they are just as bad for you as common table salt.

14 May 2014

Cumberland launches new Vaprisol product

Cumberland Pharmaceuticals Inc. today announced the launch of its active promotional campaign to support its new Vaprisol® product.

7 May 2014

Rice University researchers find new possibilities for benign, 'tunable' virus

Rice University scientists have designed a tunable virus that works like a safe deposit box. It takes two keys to open it and release its therapeutic cargo.

7 May 2014

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

UCB announced today results from the PRECiSE 3 7-year open label extension clinical trial of Cimzia (certolizumab pegol), the longest continuous trial of an anti-TNF therapy evaluating long-term safety in Crohn's disease.

6 May 2014

Standard test that measures everyday activities may help prevent rapid return to inpatient care

Patients freshly discharged from acute care hospitals with low scores on a standard test that measures how well they perform such everyday activities as moving from a bed to a chair are far more likely to need readmission to a hospital within 30 days than those who score better, according to new Johns Hopkins research.

6 May 2014

Researchers find links between hospital readmission rates and social factors

Factors like the level of poverty in a neighborhood, living alone, and age affect a patient's chances of being readmitted to a hospital after discharge, even after possible variations in quality of care in the hospital have been taken into account.

6 May 2014

Review: Stem cell therapy for chronic ischaemic heart disease

Stem cell therapies work as a complement to standard treatments, potentially cutting the number of deaths after a year, suggests evidence from the latest Cochrane review: Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.

30 Apr 2014

Study finds that Medicare patients with dementia more likely to be readmitted within 30 days

A review of more than 25,000 admissions of Medicare beneficiaries to Rhode Island hospitals has found that patients with a documented diagnosis of dementia are nearly 20 percent more likely to be readmitted within 30 days than those without dementia.

30 Apr 2014

Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

Scientists at Icahn School of Medicine at Mount Sinai, along with collaborators at institutions in India, Italy, and Japan, have identified the first gene linked to childhood-onset familial dilated cardiomyopathy (DCM), one of the most common heart muscle diseases in children.

29 Apr 2014

iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions

iGetBetter, a supplier of post-acute care transition solutions designed to help reduce hospital readmissions, and the Massachusetts Hospital Association (MHA), the primary representative of the hospital community in the commonwealth, announced today that iGetBetter will join MHA and contribute to efforts now underway by Massachusetts hospitals to improve post-discharge care transition and reduce hospital readmissions.

17 Apr 2014

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded $2.1 million from the National Institutes of Health to study the therapeutic potential of safer and more effective alternatives to the current crop of anti-diabetic drugs, which have been limited in their use due to side effects including bone loss and congestive heart failure.

17 Apr 2014

TSRI reveals new aspects of more potent anti-diabetic drugs with fewer serious side effects

8 Apr 2014

Findings could lead to more potent anti-diabetic drugs with fewer side effects

Scientists thought they basically knew how the most common drugs used to treat type 2 diabetes worked, but a new study from the Florida campus of The Scripps Research Institute (TSRI) reveals unexpected new aspects of the process. These findings could eventually lead to more potent anti-diabetic drugs with fewer serious side effects.

7 Apr 2014

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Ablative Solutions, Inc., a privately-held clinical stage company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Peregrine System(TM) Infusion Catheter.

3 Apr 2014

Congestive Heart Failure News and Research

New book documents groundbreaking studies on modified citrus pectin

FDA approves Trimel’s Natesto nasal gel to treat adult males with low testosterone

Sanofi presents Phase II trial results for investigational vaccine for prevention of CDI

Higher BMI linked with reduced mortality risk in patients with pulmonary hypertension

Investigators find effective treatment for life-threatening angioedema attacks in ED

Intensive insulin treatment improves survival for diabetic heart attack patients

Study reveals sea salt and table salt have equivalent sodium content

Cumberland launches new Vaprisol product

Rice University researchers find new possibilities for benign, 'tunable' virus

UCB announces results from PRECiSE clinical trial of Cimzia in patients with Crohn's disease

Standard test that measures everyday activities may help prevent rapid return to inpatient care

Researchers find links between hospital readmission rates and social factors

Review: Stem cell therapy for chronic ischaemic heart disease

Study finds that Medicare patients with dementia more likely to be readmitted within 30 days

Scientists identify first gene linked to childhood-onset familial dilated cardiomyopathy

iGetBetter joins Massachusetts Hospital Association to reduce hospital readmissions

TSRI scientist receives $2.1M grant to study therapeutic potential of alternatives to current crop of anti-diabetic drugs

TSRI reveals new aspects of more potent anti-diabetic drugs with fewer serious side effects

Findings could lead to more potent anti-diabetic drugs with fewer side effects

Ablative Solutions’ Peregrine System Infusion Catheter receives FDA clearance

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News